Sorrento Therapeutics, Inc. Quarterly Goodwill in USD from Q4 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Sorrento Therapeutics, Inc. quarterly Goodwill history and growth rate from Q4 2013 to Q2 2023.
  • Sorrento Therapeutics, Inc. Goodwill for the quarter ending June 30, 2023 was $80.3M, a 1.33% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $80.3M -$1.08M -1.33% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $80.3M +$744K +0.94% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $80.3M +$744K +0.94% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $80.2M +$27.3M +51.6% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $81.4M +$28.5M +53.8% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $79.5M +$36M +82.6% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $79.5M +$36M +82.6% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $52.9M +$14.6M +38.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $52.9M +$14.6M +38.1% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $43.6M +$5.26M +13.7% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $43.6M +$5.26M +13.7% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $38.3M $0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $38.3M $0 0% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $38.3M $0 0% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $38.3M $0 0% Dec 31, 2019 10-K 2021-02-19
Q3 2019 $38.3M $0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $38.3M $0 0% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $38.3M $0 0% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $38.3M $0 0% Dec 31, 2018 10-K 2020-03-03
Q3 2018 $38.3M $0 0% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $38.3M $0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $38.3M +$1.4M +3.78% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $38.3M -$3.25M -7.82% Dec 31, 2017 8-K 2019-06-17
Q3 2017 $38.3M +$17.7M +85.7% Sep 30, 2017 10-Q/A 2018-02-27
Q2 2017 $38.3M +$17.7M +85.7% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $36.9M +$16.3M +78.9% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $41.5M +$20.9M +101% Dec 31, 2016 10-K 2018-03-16
Q3 2016 $20.6M $0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $20.6M +$8.16M +65.4% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $20.6M -$3.42M -14.2% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $20.6M -$3.42M -14.2% Dec 31, 2015 10-K/A 2017-03-27
Q3 2015 $20.6M -$3.42M -14.2% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 $12.5M -$11.6M -48.1% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $24M $0 0% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $24M $0 0% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $24M Sep 30, 2014 10-Q 2014-11-04
Q2 2014 $24M Jun 30, 2014 10-Q 2014-08-06
Q1 2014 $24M Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $24M Dec 31, 2013 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.